Northwestern University Clinical and Translational Science Institute (NUCATS)
西北大学临床与转化科学研究所 (NUCATS)
基本信息
- 批准号:10408296
- 负责人:
- 金额:$ 22.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-08-12 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AchievementAddressAdoptedAdultAnalgesicsApplied ResearchAreaArtsAutomobile DrivingBiomedical ResearchBiometryBiotechnologyBusinessesCancer CenterCardiologyCaringChemistryChicagoChildChild HealthChildhoodClinicalClinical ResearchClinical SciencesClinical TrialsCollaborationsCommunitiesCommunity PhysicianComprehensive Cancer CenterData ScienceDermatologyDevelopmentDiagnosticEcosystemEducationEngineeringEnvironmentEvaluationEvolutionFosteringFundingFutureGoalsHealthHealthcareHigh Density LipoproteinsHospitalsHousingHumanHypersensitivityImmunologyIndividualIndustrializationInformaticsInformation TechnologyInfrastructureInstitutesInstitutionInstitutional PolicyInstitutional Review BoardsIntensive CareInterdisciplinary StudyLeadLearningLettersLocationLongevityLymphomaMarketingMaternal-fetal medicineMedical DeviceMedicineMethodsMissionNanotechnologyNeurologyNeurosurgical ProceduresNursing FacultyOffice ManagementPatient Outcomes AssessmentsPediatric HospitalsPharmacologyPhysical MedicinePhysical RehabilitationPhysiologyPopulation SciencesPreventive MedicineProcessPublic HealthRehabilitation therapyReportingReproducibilityResearchResearch InfrastructureResearch MethodologyResearch PersonnelResourcesRoleSchoolsScienceSpeedSurveysSystemTestingTherapeuticTrainingTraining ProgramsTranslational ResearchTranslationsUnited States National Institutes of HealthUniversitiesUrologyVisionWorkarmbasecancer clinical trialcare systemsclinical careclinical encounterclinical practicecollegecommercializationdesigndigitaldrug developmentexperimental studyhealth care deliveryimprovedinnovationmaterials sciencemedical schoolsnanobiosensornewsnoveloutreachparticlepatient populationprecision medicineprogramsresearch studysurgery outcometherapeutic developmenttoolundergraduate student
项目摘要
Contact PD/PI: LLOYD-JONES, DONALD M
ABSTRACT. The Northwestern University Clinical and Translational Sciences Institute (NUCATS) serves as
an integrated hub to advance Clinical and Translational Science (CTS) at three distinct scales: locally, at
Northwestern University (NU) and our 3 nationally-renowned clinical partners; regionally, across Chicago and
in collaboration with the other two Chicago CTSA hubs and our many community stakeholder partners; and,
nationally, through our active participation in the CTSA Consortium. By leveraging continuous CTSA funding
since 2008, as well as substantial financial and in-kind support from NU and our partners, NUCATS has
succeeded at all three scales, evolving into a mature, balanced, highly-functioning CTSA with a broad portfolio
of leading-edge programs spanning T0 through T4. Looking to the future, we recognize that there continue to
be exciting strategic opportunities for innovation and improvement, and NUCATS is not afraid to experiment
upon itself to achieve our mission of speeding transformative research discoveries to patients and the
population, in order to improve human health. We will build on this legacy through five broad-based Global
Objectives, which focus on: expanding and further integrating research into clinical care systems and
processes, with the ultimate goal that every clinical encounter can be an opportunity for research participation,
precision medicine, and learning to improve human health for all; accelerating local, regional, and national CTS
by enhancing our existing integrated digital research infrastructure to develop and apply new, leading-edge
informatics and data science tools to catalyze research, education, collaboration, engagement, evaluation, and
dissemination; broadening our community and stakeholder engagement and advance team science to enable
high-functioning, stakeholder-engaged, multi-disciplinary research teams that have impact across the
spectrum of CTS; developing, demonstrating, disseminating, and adopting innovative and sustainable CTS
methods and processes to accelerate translation and foster a culture of rigor, reproducibility, evaluation, and
continuous improvement across the CTSA consortium; and innovating, testing, and disseminating novel
training programs to cultivate, equip, and empower the diverse translational research workforce of tomorrow.
We propose to leverage CTSA funding to address key strategic opportunities and critical barriers to CTS, not
only at NUCATS, but across Chicagoland and the CTSA consortium. In doing so, we anticipate that NUCATS
will continue be a central player in the ongoing evolution of the role of CTSA Program in accelerating CTS to
improve human health.
Page 236
Project Summary/Abstract
Contact PD/PI: LLOYD-JONES, DONALD M
联系PD/PI:LLOYD-JONES,DONALD M
摘要。西北大学临床和转化科学研究所(NUCATS)
一个综合中心,以三个不同的规模推进临床和转化科学(CTS):本地,
西北大学(NU)和我们的3个全国知名的临床合作伙伴;区域,横跨芝加哥和
与其他两个芝加哥CTSA中心和我们的许多社区利益相关者合作伙伴合作;
通过我们积极参与CTSA联盟,在全国范围内。通过利用持续的CTSA资金
自2008年以来,以及大量的财政和实物支持,从NU和我们的合作伙伴,NUCATS已
在所有三个规模上都取得了成功,发展成为一个成熟、平衡、功能强大的CTSA,拥有广泛的产品组合
从T0到T4的前沿项目展望未来,我们认识到,
是创新和改进的激动人心的战略机遇,NUCATS不怕实验
为了实现我们的使命,加速变革性的研究发现,以病人和
人口,以改善人类健康。我们将在这一传统的基础上,通过五个广泛的全球
目标,重点是:扩大和进一步整合研究到临床护理系统,
过程,最终目标是每一次临床接触都可以成为参与研究的机会,
精准医学,学习改善所有人的人类健康;加速地方,区域和国家的CTS
通过加强我们现有的综合数字研究基础设施,开发和应用新的、领先的
信息学和数据科学工具,以促进研究,教育,协作,参与,评估和
传播;扩大我们的社区和利益相关者的参与,推进团队科学,
高功能,企业主参与,多学科的研究团队,在整个影响力
CTS的范围;开发,展示,传播和采用创新和可持续的CTS
方法和流程,以加快翻译,并培养严谨,可重复性,评估和
CTSA联盟的持续改进;创新,测试和传播新的
培训计划,以培养,装备,并赋予未来的多样化的翻译研究队伍。
我们建议利用CTSA资金来应对CTS的关键战略机遇和关键障碍,而不是
只有在NUCATS,但在芝加哥和CTSA财团。在这样做的时候,我们预计NUCATS
将继续在CTSA计划的不断发展中发挥核心作用,加速CTS,
改善人类健康。
第236页
项目总结/摘要
联系PD/PI:LLOYD-JONES,DONALD M
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Richard D'Aquila其他文献
Richard D'Aquila的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Richard D'Aquila', 18)}}的其他基金
Pathogenesis of Rebound SIV/HIV Viremia after Antiretrovral Therapy
抗逆转录病毒治疗后反弹 SIV/HIV 病毒血症的发病机制
- 批准号:
10224629 - 财政年份:2017
- 资助金额:
$ 22.6万 - 项目类别:
Pathogenesis of Rebound SIV/HIV Viremia after Antiretrovral Therapy
抗逆转录病毒治疗后反弹 SIV/HIV 病毒血症的发病机制
- 批准号:
10024236 - 财政年份:2017
- 资助金额:
$ 22.6万 - 项目类别:
Pathogenesis of Rebound SIV/HIV Viremia After Antiretroviral Therapy
抗逆转录病毒治疗后反弹 SIV/HIV 病毒血症的发病机制
- 批准号:
10224630 - 财政年份:2017
- 资助金额:
$ 22.6万 - 项目类别:
Cellular Metabolic Reprogramming and Virus Infectivity
细胞代谢重编程和病毒感染性
- 批准号:
10224633 - 财政年份:2017
- 资助金额:
$ 22.6万 - 项目类别:
Pathogenesis of Rebound SIV/HIV Viremia after Antiretrovral Therapy
抗逆转录病毒治疗后反弹 SIV/HIV 病毒血症的发病机制
- 批准号:
9323662 - 财政年份:2017
- 资助金额:
$ 22.6万 - 项目类别:
Northwestern University Clinical and Translational Science Institute (NUCATS)
西北大学临床与转化科学研究所 (NUCATS)
- 批准号:
10162749 - 财政年份:2015
- 资助金额:
$ 22.6万 - 项目类别:
Northwestern University Clinical and Translational Science Institute (NUCATS)
西北大学临床与转化科学研究所 (NUCATS)
- 批准号:
10653872 - 财政年份:2015
- 资助金额:
$ 22.6万 - 项目类别:
Northwestern University Clinical and Translational Science Institute (NUCATS)
西北大学临床与转化科学研究所 (NUCATS)
- 批准号:
10195329 - 财政年份:2015
- 资助金额:
$ 22.6万 - 项目类别:
Northwestern University Clinical and Translational Science Institute (NUCATS)
西北大学临床与转化科学研究所 (NUCATS)
- 批准号:
10158665 - 财政年份:2015
- 资助金额:
$ 22.6万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 22.6万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 22.6万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 22.6万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 22.6万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 22.6万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 22.6万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 22.6万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 22.6万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 22.6万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 22.6万 - 项目类别:
Research Grant














{{item.name}}会员




